Year: 2018
Type: review
Source: Journal of Thoracic Oncology
Institutions: Mayo Clinic, Università Campus Bio-Medico, University of Hawaii Cancer Center, University of Leicester, University Hospitals of Leicester NHS Trust, Aichi Cancer Center Research Institute, The University of Western Australia, Mahidol University, Ramathibodi Hospital, Zhejiang Cancer Hospital, NYU Langone Health, New York University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Hawaii Community Foundation, Mesothelioma Applied Research Foundation, AstraZeneca, Wayne State University, University of Hawaiʻi Foundation, Cancer Research UK, Eisai, Kyowa Hakko Kirin, National Institutes of Health, Genentech, Japan Society for the Promotion of Science, National Cancer Institute
Awards: Development of novel molecular diagnostic and therapeutic tools based on genomic information of malignant mesothelioma, The Role of HMGB1 in the Pathogenesis of Mesothelioma, The EDRN Mesothelioma Biomarker Discovery Laboratory, G2397841216, Development of a novel therapeutic modality against both cancerous and inflammatory diseases based on the understanding of the characteristics of mesothelial cells, Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection, G665719943
OpenAlex ID: W2794056047